Complete Filing Data
BeOne Medicines Ltd. reported Net Income Loss of $286.93 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BeOne Medicines Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $286.9M | -$644.8M | -$881.7M | -$2.00B | -$1.46B | -$1.62B | -$948.6M | -$673.8M | -$93.1M | -$119.2M | -$57.1M | -$18.3M |
| Cost of Revenue * | $286.5M | $164.9M | $70.7M | $71.2M | $28.7M | $5.0M | $0.00 | |||||
| Revenue * | $5.34B | $3.81B | $2.46B | $1.42B | $1.18B | $308.9M | $428.2M | $198.2M | $238.4M | $1.1M | $8.8M | $13.0M |
| Operating Income Loss | $447.1M | -$568.2M | -$1.21B | -$1.79B | -$1.44B | -$1.66B | -$959.9M | -$705.8M | -$98.5M | -$117.1M | -$56.7M | -$15.8M |
| Research And Development Expense | $2.15B | $1.95B | $1.78B | $1.64B | $1.46B | $1.29B | $927.3M | $679.0M | $269.0M | $98.0M | $58.3M | $21.9M |
| Income Tax Expense Benefit | $129.9M | $111.8M | $55.9M | $42.8M | $19.2M | $10.4M | $7.0M | -$15.8M | $2.2M | $54.0K | $0.00 | $0.00 |
| Other Nonoperating Income Expense | -$42.6M | -$12.6M | $307.9M | -$223.9M | $15.9M | $37.5M | $7.2M | $2.0M | $11.5M | -$972.0K | $1.2M | $600.0K |
| Comprehensive Income Net Of Tax | $357.7M | -$694.3M | -$903.7M | -$2.10B | -$1.45B | -$1.61B | -$958.2M | -$672.0M | -$92.6M | -$118.4M | -$59.0M | -$18.5M |
| Selling General And Administrative Expense | $2.08B | $1.83B | $1.51B | $1.28B | $990.1M | $600.2M | $388.2M | $195.4M | $62.6M | $20.1M | $7.3M | |
| Interest Income Expense Net | $74.0M | $52.5M | -$15.8M | $2.0M | $9.1M | $13.9M | -$4.1M | $383.0K | $559.0K | -$3.5M | ||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$825.8M | -$1.96B | -$1.44B | -$1.62B | -$943.6M | -$689.8M | -$91.1M | -$119.2M | -$57.1M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$25.5M | -$90.4M | $13.7M | $23.6M | -$9.4M | -$478.0K | $851.0K | -$245.0K | -$749.0K | -$168.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$903.7M | -$2.10B | -$1.45B | -$1.61B | -$960.5M | -$672.4M | -$92.7M | -$118.4M | -$59.0M | -$18.8M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$4.6M | -$419.0K | -$448.0K | $2.1M | -$296.0K | $1.1M | -$1.2M | |||||
| Income Taxes Paid Net | $69.4M | $56.0M | $29.5M | $15.7M | $10.6M | $9.0M | $12.4M | $29.3M | $25.0K | |||
| Other Comprehensive Income Loss Net Of Tax | -$49.5M | -$22.0M | -$95.4M | $11.0M | $15.1M | -$9.9M | $1.7M | |||||
| Deferred Income Taxes And Tax Credits | $9.5M | $26.0M | $689.0K | $2.1M | $3.4M | $261.0K | -$9.2M | -$21.9M | -$5.8M | -$768.0K | ||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | -$3.6M | -$2.0M | -$264.0K | -$194.0K | $0.00 | -$268.0K | ||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | -$3.5M | -$2.3M | -$352.0K | -$105.0K | $0.00 | -$274.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $124.8M | $94.3M | $1.3M | -$121.4M | -$120.4M | -$251.2M | $215.4M | -$381.1M | -$348.4M | -$557.6M | -$565.7M | -$435.2M | -$438.1M | -$480.3M | $66.5M | -$472.7M | -$425.2M | -$335.2M | -$363.7M | -$388.1M | -$307.4M | -$85.6M | -$167.6M | -$268.3M | -$144.0M | -$156.9M | -$104.6M | -$99.3M | $117.4M | -$60.5M | -$50.6M | -$37.6M | -$35.5M | -$24.1M | -$22.0M | -$27.3M | -$14.0M | -$5.6M | -$10.2M |
| Cost of Revenue * | $96.3M | $96.0M | $81.8M | $76.5M | $71.2M | $65.2M | $47.4M | $36.3M | $32.7M | $21.1M | $14.3M | $14.1M | $20.1M | $17.8M | $15.3M | $8.7M | $6.3M | $4.6M | $1.9M | ||||||||||||||||||||
| Revenue * | $1.41B | $1.32B | $1.12B | $1.00B | $929.2M | $751.7M | $781.3M | $595.3M | $447.8M | $387.6M | $341.6M | $306.6M | $206.4M | $150.0M | $605.9M | $100.1M | $91.1M | $65.6M | $52.1M | $56.9M | $50.1M | $243.3M | $77.8M | $58.7M | $54.2M | $52.8M | $32.5M | $18.2M | $220.2M | $0.00 | $0.00 | $393.0K | $677.0K | $4.7M | $1.4M | $1.4M | $1.4M | ||
| Operating Income Loss | $163.1M | $87.9M | $11.1M | -$120.3M | -$107.2M | -$261.3M | -$134.0M | -$318.7M | -$371.3M | -$438.4M | -$439.4M | -$443.3M | -$462.3M | -$474.8M | $70.2M | -$484.9M | -$440.1M | -$358.9M | -$373.8M | -$388.0M | -$312.3M | -$85.8M | -$173.8M | -$280.8M | -$151.1M | -$163.1M | -$110.8M | -$103.8M | $114.9M | -$58.0M | -$51.5M | -$37.3M | -$34.8M | -$24.6M | -$20.3M | -$26.4M | -$14.0M | -$6.6M | -$9.8M |
| Research And Development Expense | $523.7M | $524.9M | $481.9M | $496.2M | $454.5M | $460.6M | $453.3M | $422.8M | $408.6M | $426.4M | $378.2M | $389.9M | $351.9M | $356.1M | $320.7M | $349.1M | $286.0M | $304.3M | $237.0M | $228.8M | $178.4M | $147.6M | $164.3M | $109.7M | $87.7M | $47.2M | $42.8M | $30.1M | $21.1M | $17.9M | $13.4M | $6.7M | $10.1M | ||||||
| Income Tax Expense Benefit | $22.3M | $5.2M | $19.6M | $23.0M | $14.5M | $7.7M | $13.9M | $13.7M | $11.5M | $6.3M | $8.1M | $13.9M | $5.0M | -$230.0K | -$4.6M | -$8.4M | -$1.5M | $1.6M | -$3.2M | $2.1M | $519.0K | -$472.0K | -$3.4M | -$3.4M | -$3.1M | $201.0K | $180.0K | $127.0K | $135.0K | $44.0K | $0.00 | $0.00 | $0.00 | ||||||
| Other Nonoperating Income Expense | -$19.0M | $8.2M | $4.0M | $11.3M | -$12.0M | $1.8M | $336.7M | -$63.8M | $18.3M | -$125.6M | -$129.6M | $12.0M | $31.5M | -$867.0K | -$4.1M | $5.7M | $20.0M | $3.7M | -$1.8M | -$878.0K | $1.7M | $1.6M | $75.0K | $729.0K | $1.1M | -$475.0K | $913.0K | -$327.0K | $746.0K | $313.0K | |||||||||
| Comprehensive Income Net Of Tax | $137.3M | $122.9M | $7.9M | -$64.4M | -$129.2M | -$283.3M | $214.2M | -$465.8M | -$330.0M | -$636.6M | -$665.6M | -$435.7M | -$437.6M | -$471.5M | $62.8M | -$416.3M | -$338.0M | -$362.3M | -$322.0M | -$91.9M | -$163.1M | -$147.9M | -$154.1M | -$104.1M | $117.7M | -$60.0M | -$50.5M | -$35.0M | -$24.3M | -$21.4M | |||||||||
| Selling General And Administrative Expense | $529.0M | $537.9M | $459.3M | $455.2M | $443.7M | $427.4M | $365.7M | $395.0M | $328.5M | $322.9M | $331.4M | $294.6M | $269.2M | $232.3M | $182.1M | $160.8M | $124.0M | $107.1M | $105.0M | $82.2M | $57.6M | $48.8M | $45.2M | $28.9M | $15.6M | $10.8M | $8.8M | $4.7M | |||||||||||
| Interest Income Expense Net | $13.2M | $16.2M | $26.6M | $15.1M | $16.0M | $12.8M | $11.4M | $10.1M | -$2.2M | -$4.9M | -$4.2M | -$614.0K | $1.1M | $6.7M | $2.2M | $2.9M | $4.5M | $4.6M | $1.9M | $1.6M | -$1.8M | -$2.0M | $186.0K | -$75.0K | $121.0K | $290.0K | |||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $229.3M | -$367.5M | -$336.9M | -$551.2M | -$557.6M | -$421.2M | -$433.1M | -$480.6M | $61.9M | -$435.0M | -$337.8M | -$363.4M | -$311.9M | -$83.8M | -$167.6M | -$145.0M | -$161.1M | -$108.5M | $114.2M | -$60.5M | -$50.4M | -$35.4M | -$24.0M | -$22.0M | -$14.0M | -$5.6M | -$10.2M | ||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$32.2M | $13.3M | $664.0K | $9.6M | -$3.8M | $10.1M | $1.7M | -$4.3M | -$13.7M | -$7.3M | $3.8M | -$4.2M | $2.0M | $272.0K | $341.0K | $554.0K | $90.0K | $377.0K | -$486.0K | $97.0K | -$428.0K | -$32.0K | -$50.0K | ||||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$283.3M | -$330.0M | -$413.4M | -$471.5M | $62.8M | -$417.5M | -$339.1M | -$363.6M | -$323.6M | -$92.4M | -$163.6M | -$148.4M | -$155.0M | -$104.5M | $117.7M | -$60.1M | -$50.5M | -$35.0M | -$24.3M | -$21.4M | -$14.7M | -$6.0M | -$10.3M | ||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$68.0K | -$599.0K | -$473.0K | -$1.0M | -$4.5M | $5.7M | -$1.3M | $901.0K | $685.0K | $354.0K | $719.0K | $329.0K | $51.0K | $19.0K | -$12.0K | $121.0K | $275.0K | $461.0K | -$303.0K | -$365.0K | -$55.0K | ||||||||||||||||||
| Income Taxes Paid Net | $9.3M | $2.5M | $7.6M | $736.0K | $478.0K | $531.0K | $360.0K | $329.0K | $76.0K | ||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $28.6M | $6.7M | $56.9M | -$8.8M | -$32.2M | -$1.2M | -$84.7M | $18.4M | -$79.1M | -$99.9M | -$496.0K | $485.0K | $8.9M | -$3.7M | $9.1M | -$2.7M | $1.3M | -$14.9M | -$6.4M | $4.4M | |||||||||||||||||||
| Deferred Income Taxes And Tax Credits | $36.0K | $50.0K | -$12.3M | -$206.0K | -$983.0K | -$4.1M | -$2.2M | ||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | -$1.4M | -$1.1M | -$1.2M | -$1.3M | -$384.0K | -$429.0K | -$461.0K | -$828.0K | -$520.0K | -$102.0K | -$135.0K | |||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | -$1.2M | -$1.1M | -$1.3M | -$1.6M | -$523.0K | -$535.0K | -$486.0K | -$870.0K | -$456.0K | -$70.0K | -$108.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.36B | $3.33B | $3.54B | $4.38B | $6.13B | $3.80B | $962.2M | $1.74B | $669.8M | $352.9M | -$101.8M | -$53.0M | -$37.0M |
| Cash And Cash Equivalents At Carrying Value | $4.55B | $2.63B | $3.17B | $3.87B | $4.38B | $1.38B | $618.0M | $712.9M | $239.6M | $87.5M | $17.9M | $13.9M | $3.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.61B | $2.64B | $3.19B | $3.88B | $4.38B | $1.39B | $620.8M | $740.7M | $239.6M | $87.5M | $17.9M | ||
| Long Term Debt Noncurrent | $961.9M | $166.5M | $197.6M | $1.44B | $1.29B | $183.6M | $580.0M | $40.8M | $9.2M | $17.3M | |||
| Long Term Debt Current | $57.3M | $851.5M | $688.4M | $2.27B | $427.6M | $335.0M | $8.7M | $9.2M | |||||
| Restricted Cash And Cash Equivalents At Carrying Value | $41.3M | $9.3M | $11.5M | $196.0K | $328.0K | $307.0K | $288.0K | $14.5M | $0.00 | $0.00 | |||
| Restricted Cash And Cash Equivalents Noncurrent | $20.8M | $2.0M | $2.7M | $5.3M | $6.9M | $7.7M | $2.5M | $13.2M | $0.00 | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$8.32B | -$8.61B | -$7.96B | -$7.08B | -$5.08B | -$3.55B | -$1.96B | -$1.01B | -$330.5M | -$237.4M | -$118.2M | ||
| Property Plant And Equipment Net | $1.64B | $1.58B | $1.32B | $845.9M | $587.6M | $357.7M | $242.4M | $157.1M | $62.6M | $26.0M | $6.6M | ||
| Prepaid Expense And Other Assets Current | $212.8M | $192.9M | $257.5M | $216.6M | $270.2M | $160.0M | $90.2M | $90.6M | $35.6M | $6.2M | $5.8M | ||
| Other Liabilities Noncurrent | $80.2M | $66.7M | $50.8M | $46.1M | $54.2M | $57.4M | $46.6M | $48.8M | $32.0M | $564.0K | $105.0K | ||
| Other Assets Noncurrent | $102.4M | $160.5M | $125.4M | $175.7M | $163.0M | $113.1M | $68.5M | $53.8M | $42.9M | $4.7M | $3.9M | ||
| Liabilities Noncurrent | $2.00B | $373.8M | $457.8M | $527.4M | $803.4M | $656.3M | $323.6M | $249.6M | $212.3M | $17.8M | $7.3M | ||
| Liabilities Current | $1.83B | $2.21B | $1.81B | $1.47B | $1.60B | $1.08B | $310.3M | $246.5M | $150.0M | $35.1M | $35.2M | ||
| Liabilities And Stockholders Equity | $8.19B | $5.92B | $5.81B | $6.38B | $8.54B | $5.60B | $1.61B | $2.25B | $1.05B | $405.8M | $116.8M | ||
| Liabilities | $3.83B | $2.59B | $2.27B | $2.00B | $2.40B | $1.73B | $633.9M | $496.0M | $362.2M | $52.9M | $42.4M | ||
| Common Stock Value | $144.0K | $138.0K | $135.0K | $135.0K | $133.0K | $118.0K | $79.0K | $77.0K | $59.0K | $52.0K | $12.0K | ||
| Assets Noncurrent | $1.95B | $1.93B | $1.60B | $1.17B | $921.6M | $640.1M | $439.6M | $305.8M | $133.0M | $31.4M | $10.5M | ||
| Assets Current | $6.23B | $3.99B | $4.20B | $5.21B | $7.61B | $4.96B | $1.17B | $1.94B | $913.5M | $374.4M | $106.3M | ||
| Assets | $8.19B | $5.92B | $5.81B | $6.38B | $8.54B | $5.60B | $1.61B | $2.25B | $1.05B | $405.8M | $116.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$78.2M | -$149.0M | -$99.4M | -$77.4M | $18.0M | $6.9M | -$8.0M | $1.5M | -$480.0K | -$946.0K | -$1.8M | ||
| Accounts Payable Current | $479.0M | $405.0M | $315.1M | $294.8M | $262.4M | $232.0M | $122.5M | $113.3M | $69.8M | $12.0M | $9.0M | ||
| Taxes Payable Current | $41.6M | $25.9M | $23.0M | $25.2M | $21.4M | $20.4M | $13.5M | $5.9M | $9.2M | $804.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.97B | -$547.2M | -$689.1M | -$507.9M | $2.99B | $769.2M | -$119.9M | $501.1M | $152.1M | $69.6M | |||
| Inventory Net | $608.2M | $495.0M | $416.1M | $282.3M | $242.6M | $89.3M | $28.6M | $16.2M | $10.9M | ||||
| Finite Lived Intangible Assets Net | $62.7M | $51.1M | $57.1M | $40.6M | $46.7M | $5.0M | $5.8M | $7.2M | $7.3M | ||||
| Accounts Receivable Net Current | $865.1M | $676.3M | $358.0M | $173.2M | $483.1M | $60.4M | $70.9M | $41.1M | $29.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.13B | $3.77B | $3.50B | $3.44B | $3.37B | $3.36B | $3.54B | $3.76B | $3.80B | $4.16B | $4.38B | $4.66B | $5.20B | $5.77B | $3.36B | $3.61B | $4.00B | $3.87B | $4.29B | $2.54B | $2.81B | $1.28B | $1.55B | $1.61B | $1.97B | $1.21B | $1.34B | $750.1M | $255.8M | $308.4M | $187.8M | $220.0M | $243.1M | ||||
| Cash And Cash Equivalents At Carrying Value | $4.04B | $2.76B | $2.52B | $2.70B | $2.59B | $2.79B | $3.07B | $3.41B | $3.54B | $4.20B | $4.53B | $4.35B | $1.38B | $1.78B | $1.90B | $1.46B | $1.35B | $1.96B | $856.9M | $918.9M | $764.5M | $643.5M | $438.4M | $490.6M | $208.5M | $261.0M | $97.8M | $85.5M | $58.1M | $208.5M | $27.5M | $25.2M | $13.4M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.11B | $2.79B | $2.53B | $2.71B | $2.62B | $2.81B | $3.08B | $3.42B | $3.54B | $4.20B | $4.54B | $4.35B | $1.39B | $1.79B | $1.91B | $1.47B | $1.35B | $1.96B | $900.8M | $942.7M | $788.4M | $710.8M | $470.0M | $508.1M | $208.5M | $261.0M | $97.8M | ||||||||||
| Long Term Debt Noncurrent | $146.1M | $160.2M | $1.32B | $1.35B | $199.0M | $1.48B | $1.50B | $1.42B | $1.48B | $185.2M | $201.6M | $200.9M | $194.9M | $1.26B | $151.6M | $131.5M | $81.9M | $104.2M | $84.5M | $77.5M | $40.8M | $51.5M | $9.6M | ||||||||||||||
| Long Term Debt Current | $808.4M | $763.5M | $6.06B | $851.7M | $5.97B | $2.40B | $3.05B | $281.8M | $441.3M | $380.7M | $2.58B | $2.85B | $2.81B | $405.0M | $50.2M | $26.1M | $11.3M | $0.00 | $700.0K | $8.7M | $8.9M | $8.7M | $9.1M | $9.6M | $9.0M | ||||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $53.0M | $15.8M | $11.3M | $9.3M | $23.2M | $11.4M | $11.5M | $9.7M | $159.0K | $191.0K | $333.0K | $330.0K | $330.0K | $310.0K | $305.0K | $295.0K | $283.0K | $282.0K | $14.3M | $14.6M | $14.9M | $14.6M | $31.6M | $17.5M | $0.00 | ||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $20.7M | $14.2M | $2.8M | $2.2M | $2.1M | $2.6M | $2.0M | $1.5M | $5.0M | $3.2M | $3.9M | $7.0M | $6.1M | $9.9M | $8.3M | $5.0M | $4.6M | $2.4M | $30.4M | $9.2M | $9.0M | $52.8M | $0.00 | $0.00 | $0.00 | ||||||||||||
| Retained Earnings Accumulated Deficit | -$8.39B | -$8.51B | -$8.61B | -$8.45B | -$8.33B | -$8.21B | -$7.59B | -$7.81B | -$7.43B | -$6.64B | -$5.97B | -$5.40B | -$4.38B | -$3.97B | -$3.49B | -$3.08B | -$2.65B | -$2.32B | -$1.57B | -$1.26B | -$1.17B | -$739.0M | -$594.9M | -$438.0M | -$231.2M | -$348.6M | -$288.0M | -$199.8M | -$164.3M | -$140.2M | |||||||
| Property Plant And Equipment Net | $1.63B | $1.62B | $1.60B | $1.56B | $1.52B | $1.42B | $1.18B | $1.03B | $925.4M | $681.9M | $633.1M | $624.7M | $450.8M | $395.2M | $373.9M | $291.2M | $258.1M | $240.3M | $226.5M | $212.7M | $197.8M | $111.3M | $90.5M | $77.0M | $55.3M | $33.8M | $30.7M | $16.6M | $9.8M | $7.7M | |||||||
| Prepaid Expense And Other Assets Current | $232.6M | $280.5M | $168.2M | $209.1M | $273.7M | $231.7M | $241.7M | $255.1M | $264.8M | $199.8M | $207.4M | $266.4M | $235.0M | $225.5M | $171.4M | $150.9M | $144.5M | $126.3M | $95.9M | $96.2M | $89.9M | $69.9M | $63.3M | $49.4M | $17.7M | $11.3M | $8.7M | $6.3M | $6.1M | $4.6M | |||||||
| Other Liabilities Noncurrent | $64.1M | $63.1M | $65.6M | $50.6M | $51.5M | $48.9M | $42.0M | $43.1M | $45.6M | $45.2M | $48.4M | $51.8M | $54.6M | $55.3M | $55.3M | $47.9M | $46.5M | $45.3M | $36.6M | $38.1M | $39.0M | $34.9M | $21.8M | $22.9M | $744.0K | $1.1M | $893.0K | $247.0K | $165.0K | $89.0K | |||||||
| Other Assets Noncurrent | $136.2M | $161.7M | $149.9M | $201.2M | $199.3M | $199.0M | $140.9M | $147.5M | $173.4M | $140.6M | $131.0M | $164.6M | $175.1M | $132.2M | $127.8M | $162.6M | $112.4M | $94.3M | $64.8M | $60.2M | $58.6M | $28.9M | $11.5M | $14.2M | $2.1M | $16.7M | $6.9M | $8.9M | $8.7M | $5.7M | |||||||
| Liabilities Noncurrent | $1.13B | $318.1M | $358.3M | $369.5M | $407.2M | $425.6M | $478.3M | $525.1M | $544.9M | $659.5M | $677.3M | $759.6M | $624.8M | $675.0M | $704.9M | $624.2M | $805.6M | $788.4M | $321.1M | $307.4M | $310.7M | $236.8M | $240.8M | $208.3M | $181.4M | $153.9M | $18.3M | $18.3M | $10.7M | $6.3M | |||||||
| Liabilities Current | $2.37B | $2.21B | $1.98B | $2.03B | $1.94B | $1.88B | $1.28B | $1.41B | $1.25B | $1.41B | $1.40B | $1.38B | $1.30B | $1.24B | $1.11B | $645.7M | $551.2M | $451.8M | $265.7M | $271.7M | $238.8M | $188.4M | $186.4M | $141.9M | $103.2M | $50.0M | $50.0M | $29.3M | $20.5M | $15.8M | |||||||
| Liabilities And Stockholders Equity | $7.63B | $6.30B | $5.84B | $5.83B | $5.71B | $5.67B | $5.52B | $5.73B | $5.96B | $6.73B | $7.38B | $8.02B | $5.29B | $5.52B | $5.82B | $5.57B | $3.90B | $4.07B | $1.88B | $2.15B | $2.17B | $2.41B | $1.65B | $1.71B | $1.05B | $474.0M | $376.7M | $235.4M | $251.2M | $265.2M | |||||||
| Liabilities | $3.50B | $2.53B | $2.34B | $2.39B | $2.35B | $2.31B | $1.76B | $1.93B | $1.80B | $2.07B | $2.08B | $2.14B | $1.93B | $1.92B | $1.82B | $1.27B | $1.36B | $1.24B | $586.8M | $579.1M | $549.6M | $425.2M | $427.2M | $350.2M | $284.6M | $203.8M | $68.3M | $47.6M | $31.2M | $22.1M | |||||||
| Common Stock Value | $144.0K | $143.0K | $140.0K | $138.0K | $137.0K | $136.0K | $135.0K | $137.0K | $136.0K | $135.0K | $134.0K | $133.0K | $121.0K | $120.0K | $119.0K | $118.0K | $102.0K | $101.0K | $78.0K | $78.0K | $78.0K | $77.0K | $70.0K | $70.0K | $59.0K | $52.0K | $52.0K | $43.0K | $43.0K | $43.0K | |||||||
| Assets Noncurrent | $1.97B | $1.99B | $1.95B | $1.92B | $1.87B | $1.76B | $1.47B | $1.33B | $1.25B | $976.8M | $1.03B | $1.07B | $853.5M | $725.1M | $680.0M | $600.7M | $510.9M | $472.0M | $445.5M | $394.6M | $375.5M | $228.4M | $137.1M | $123.2M | $86.7M | $55.3M | $40.6M | $25.5M | $18.5M | $13.4M | |||||||
| Assets Current | $5.66B | $4.31B | $3.90B | $3.91B | $3.84B | $3.91B | $4.05B | $4.40B | $4.70B | $5.75B | $6.35B | $6.95B | $4.43B | $4.80B | $5.14B | $4.97B | $3.39B | $3.60B | $1.44B | $1.76B | $1.80B | $2.18B | $1.52B | $1.59B | $962.3M | $418.7M | $336.2M | $210.0M | $232.8M | $251.8M | |||||||
| Assets | $7.63B | $6.30B | $5.84B | $5.83B | $5.71B | $5.67B | $5.52B | $5.73B | $5.96B | $6.73B | $7.38B | $8.02B | $5.29B | $5.52B | $5.82B | $5.57B | $3.90B | $4.07B | $1.88B | $2.15B | $2.17B | $2.41B | $1.65B | $1.71B | $1.05B | $474.0M | $376.7M | $235.4M | $251.2M | $265.2M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$101.3M | -$113.7M | -$142.3M | -$83.5M | -$140.5M | -$131.6M | -$144.9M | -$143.7M | -$59.0M | -$161.5M | -$82.5M | $17.5M | $12.6M | $12.1M | $3.2M | -$419.0K | -$9.3M | -$6.5M | -$14.8M | -$225.0K | $6.1M | -$724.0K | $3.1M | $320.0K | $38.0K | -$322.0K | -$868.0K | -$965.0K | -$1.5M | -$1.3M | |||||||
| Accounts Payable Current | $383.7M | $360.8M | $364.5M | $307.5M | $333.0M | $356.6M | $341.9M | $267.0M | $241.4M | $252.1M | $234.4M | $236.9M | $206.2M | $168.8M | $146.9M | $146.3M | $157.2M | $98.4M | $112.3M | $148.5M | $105.3M | $85.6M | $85.9M | $52.7M | $35.2M | $24.4M | $20.5M | $7.3M | $6.1M | $3.8M | |||||||
| Taxes Payable Current | $11.2M | $5.5M | $34.1M | $14.9M | $5.3M | $27.3M | $20.2M | $17.1M | $33.9M | $22.7M | $15.6M | $38.5M | $20.9M | $13.9M | $27.5M | $9.2M | $10.4M | $19.5M | $9.1M | $2.2M | $6.9M | $1.5M | $1.2M | $9.9M | $2.9M | $3.1M | $2.6M | $294.0K | $168.0K | $33.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$108.2M | -$378.5M | -$331.3M | -$28.4M | $520.4M | $1.34B | $47.7M | $268.5M | $10.2M | ||||||||||||||||||||||||||||
| Inventory Net | $531.7M | $502.9M | $494.7M | $431.7M | $443.3M | $447.3M | $316.9M | $321.3M | $297.0M | $290.9M | $262.2M | $245.6M | $151.0M | $117.6M | $73.0M | $35.5M | $33.2M | $28.8M | $37.5M | $49.0M | $13.1M | $19.7M | $6.3M | $7.5M | $5.7M | ||||||||||||
| Finite Lived Intangible Assets Net | $63.6M | $64.9M | $50.1M | $53.9M | $53.7M | $55.2M | $53.7M | $46.9M | $39.7M | $40.8M | $43.3M | $45.8M | $14.1M | $12.0M | $4.8M | $5.2M | $5.4M | $5.6M | $6.2M | $6.5M | $6.8M | $7.3M | $6.9M | $7.1M | $7.4M | ||||||||||||
| Accounts Receivable Net Current | $863.3M | $770.8M | $717.2M | $569.0M | $529.4M | $435.3M | $309.1M | $299.3M | $309.6M | $189.2M | $172.3M | $190.8M | $129.6M | $73.8M | $84.0M | $60.3M | $61.7M | $65.6M | $55.9M | $58.1M | $59.0M | $37.4M | $33.2M | $23.5M | $10.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $1.06B | $193.4M | $416.5M | -$19.0M | $3.64B | $5.20B | $85.7M | $1.69B | $490.4M | $380.9M | $103.2M | $52.2M |
| Investing Cash Flow * | -$276.2M | -$548.4M | $60.0M | $1.08B | $640.7M | -$3.17B | $554.2M | -$637.6M | -$356.3M | -$221.8M | -$58.9M | -$33.6M |
| Operating Cash Flow * | $1.13B | -$140.6M | -$1.16B | -$1.50B | -$1.30B | -$1.28B | -$750.3M | -$547.7M | $12.8M | -$89.5M | -$39.8M | -$8.7M |
| Share Based Compensation | $510.9M | $441.6M | $367.6M | $303.2M | $240.7M | $183.5M | $134.2M | $87.1M | $42.9M | $10.6M | $10.2M | $6.6M |
| Payments To Acquire Property Plant And Equipment | $185.8M | $492.7M | $561.9M | $325.4M | $262.9M | $117.5M | $89.6M | $70.3M | $46.4M | $23.5M | $5.3M | $654.0K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $311.8M | $111.4M | $180.1M | $45.6M | $140.0M | $185.0M | $71.6M | $50.5M | $25.0M | $13.9M | $7.4M | -$761.0K |
| Increase Decrease In Accounts Payable | $79.8M | $121.5M | $21.5M | -$4.4M | $20.0M | $95.8M | $2.2M | $23.5M | $55.3M | $2.7M | $6.2M | $731.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $3.4M | $2.7M | $673.2M | $1.56B | $3.15B | $2.75B | $1.88B | $2.18B | $423.8M | $183.7M | $65.7M | $102.0K |
| Depreciation Depletion And Amortization | $141.7M | $171.8M | $87.7M | $66.3M | $46.5M | $31.8M | $18.6M | $10.4M | $4.8M | $1.9M | $1.5M | |
| Increase Decrease In Inventories | $93.2M | $91.5M | $140.9M | $56.7M | $153.3M | $58.9M | $12.3M | $5.3M | $10.9M | $0.00 | ||
| Increase Decrease In Accounts Receivable | $165.0M | $329.4M | $188.3M | -$304.1M | $423.0M | -$10.4M | $29.8M | $11.6M | $29.4M | $0.00 | ||
| Payments To Purchase In Process Research And Development | $60.7M | $31.8M | $15.0M | $143.7M | $8.5M | $109.5M | $69.0M | $70.0M | $0.00 | $0.00 | ||
| Proceeds From Long Term Lines Of Credit | $850.6M | $9.1M | $22.5M | $37.4M | $16.8M | $110.2M | $67.5M | $42.3M | $0.00 | $12.0M | $6.2M | |
| Proceeds From Short Term Debt | $233.7M | $868.3M | $661.5M | $313.8M | $406.4M | $323.7M | $0.00 | $0.00 | $2.5M | $0.00 | $322.0K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $60.0M | -$51.7M | -$8.1M | -$69.4M | $14.0M | $18.2M | -$9.5M | -$4.1M | ||||
| Increase Decrease In Contract With Customer Liability | $1.3M | $633.0K | -$255.6M | -$151.8M | $407.7M | $0.00 | -$28.0M | -$9.1M | $37.0M | -$1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$33.8M | $162.3M | -$19.9M | -$11.3M | $107.4M | $2.80B | $43.0M | $763.9M | $2.5M | $170.0M | |
| Investing Cash Flow * | -$121.9M | -$209.8M | $241.1M | $210.4M | $291.9M | -$1.11B | $172.4M | -$394.4M | $43.5M | $40.3M | $3.2M |
| Operating Cash Flow * | $44.1M | -$308.6M | -$563.8M | -$236.6M | $125.1M | -$341.9M | -$172.0M | -$104.5M | -$35.7M | -$19.8M | -$3.7M |
| Share Based Compensation | $95.5M | $88.7M | $75.3M | $65.6M | $45.8M | $38.3M | $26.4M | $17.4M | $6.0M | $2.6M | $2.3M |
| Payments To Acquire Property Plant And Equipment | $56.4M | $156.6M | $125.6M | $45.1M | $42.4M | $21.5M | $21.8M | $9.7M | $5.1M | $3.3M | $3.2M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$52.4M | -$79.3M | -$38.7M | -$78.8M | -$26.9M | $15.8M | -$8.8M | $6.1M | $2.2M | $3.2M | $862.0K |
| Increase Decrease In Accounts Payable | -$31.6M | $46.3M | -$22.6M | -$35.0M | -$73.2M | -$21.5M | -$20.4M | -$18.5M | $8.5M | -$5.3M | -$628.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $1.8M | $2.7M | $377.0M | $331.0M | $1.11B | $256.7M | $710.6M | $257.6M | $65.6M | $43.6M | $10.5M |
| Depreciation Depletion And Amortization | $32.8M | $25.3M | $20.0M | $16.6M | $9.6M | $7.8M | $3.4M | $2.2M | $864.0K | ||
| Increase Decrease In Inventories | -$4.0M | $37.3M | $13.0M | $3.0M | -$16.3M | $222.0K | -$3.1M | -$3.4M | |||
| Increase Decrease In Accounts Receivable | $31.9M | $80.0M | $136.5M | -$292.6M | $23.7M | -$3.2M | $17.9M | -$5.9M | |||
| Payments To Purchase In Process Research And Development | $60.0M | $31.8M | $0.00 | $75.0M | $8.5M | $43.0M | $29.0M | $10.0M | |||
| Proceeds From Long Term Lines Of Credit | $0.00 | $9.1M | $0.00 | $0.00 | $10.7M | $0.00 | $36.7M | $0.00 | |||
| Proceeds From Short Term Debt | $80.0M | $142.0M | $0.00 | $50.0M | $71.0M | $11.3M | $0.00 | $2.5M | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.5M | -$22.4M | $11.3M | $9.0M | -$4.1M | -$6.2M | $4.3M | $3.4M | -$129.0K | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$33.1M | -$39.7M | $150.2M | $0.00 | -$2.2M | -$1.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.19 | -$0.47 | -$0.65 | -$1.49 | -$1.21 | -$1.50 | -$1.22 | -$0.93 | -$0.17 | -$0.30 | -$0.52 | -$0.18 |
| Common Stock Shares Outstanding | 1.44B | 1.39B | 1.36B | 1.36B | 1.33B | 1.19B | 801.3M | 776.3M | 592.1M | 515.8M | 116.2M | |
| Common Stock Shares Issued | 1.54B | 1.39B | 1.36B | 1.36B | 1.33B | 1.19B | 801.3M | 776.3M | 592.1M | 515.8M | 116.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | |||
| Weighted Average Number Of Shares Outstanding Basic | 1.42B | 1.37B | 1.36B | 1.34B | 1.21B | 1.09B | 780.7M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.47B | 1.37B | 1.36B | 1.34B | 1.21B | 1.09B | 780.7M | |||||
| Earnings Per Share Basic | $0.20 | $-0.47 | $-0.65 | $-1.49 | $-1.21 | $-1.50 | $-1.22 | |||||
| Weighted Average Number Of American Depository Shares Outstanding Diluted | 113.4M | 105.3M | 104.4M | 103.1M | 92.8M | 83.5M | 60.1M | |||||
| Weighted Average Number Of American Depository Shares Outstanding Basic | 109.1M | 105.3M | 104.4M | 103.1M | 92.8M | 83.5M | 60.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.08 | $0.06 | $0.00 | -$0.09 | -$0.09 | -$0.19 | $0.15 | -$0.28 | -$0.26 | -$0.41 | -$0.42 | -$0.33 | -$0.36 | -$0.40 | $0.05 | -$0.40 | -$0.37 | -$0.33 | -$0.36 | -$0.49 | -$0.39 | -$0.11 | -$0.22 | -$0.35 | -$0.19 | -$0.22 | -$0.16 | $0.20 | -$0.12 | -$0.10 | -$0.08 | -$0.08 | -$0.06 | -$0.07 | -$0.23 | -$0.13 | -$0.05 | -$0.09 | |
| Common Stock Shares Outstanding | 1.44B | 1.43B | 1.40B | 1.39B | 1.38B | 1.36B | 1.35B | 1.38B | 1.36B | 1.35B | 1.35B | 1.33B | 1.21B | 1.20B | 1.20B | 1.18B | 1.01B | 1.01B | 78.4M | 784.4M | 777.4M | 771.1M | 701.6M | 698.9M | 589.8M | 518.9M | 518.6M | 428.5M | 427.9M | 427.4M | |||||||||
| Common Stock Shares Issued | 1.54B | 1.54B | 1.40B | 1.39B | 1.38B | 1.36B | 1.35B | 1.38B | 1.36B | 1.35B | 1.35B | 1.33B | 1.21B | 1.20B | 1.20B | 1.18B | 1.01B | 1.01B | 784.4M | 784.4M | 777.4M | 771.1M | 701.6M | 698.9M | 589.8M | 518.9M | 518.6M | 428.5M | 427.9M | 427.4M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Authorized | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | 9.50B | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 1.43B | 1.41B | 1.39B | 1.38B | 1.36B | 1.36B | 1.36B | 1.36B | 1.35B | 1.35B | 1.34B | 1.33B | 1.21B | 1.19B | 1.19B | 1.15B | 1.01B | 1.01B | 739.8M | 547.5M | 428.1M | ||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.49B | 1.46B | 1.45B | 1.38B | 1.36B | 1.36B | 1.39B | 1.36B | 1.35B | 1.35B | 1.34B | 1.33B | 1.21B | 1.19B | 1.26B | 1.15B | 1.01B | 1.01B | 739.8M | 600.6M | 428.1M | ||||||||||||||||||
| Earnings Per Share Basic | $0.09 | $0.07 | $0.00 | $-0.09 | $-0.09 | $-0.19 | $0.16 | $-0.28 | $-0.26 | $-0.41 | $-0.42 | $-0.33 | $-0.36 | $-0.40 | $0.06 | $-0.37 | $-0.33 | $-0.36 | $-0.19 | $0.21 | $-0.08 | ||||||||||||||||||
| Weighted Average Number Of American Depository Shares Outstanding Diluted | 114.5M | 112.6M | 111.2M | 105.9M | 104.7M | 104.3M | 106.9M | 104.6M | 104.2M | 103.5M | 102.8M | 102.5M | 92.8M | 91.9M | 96.7M | 88.4M | 77.7M | 77.3M | |||||||||||||||||||||
| Weighted Average Number Of American Depository Shares Outstanding Basic | 110.2M | 108.3M | 106.9M | 105.9M | 104.7M | 104.3M | 104.7M | 104.6M | 104.2M | 103.5M | 102.8M | 102.5M | 92.8M | 91.9M | 91.5M | 88.4M | 77.7M | 77.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $4.23B | $3.78B | $3.29B | $2.92B | $2.45B | $1.97B | $1.39B | $904.0M | $336.8M | $118.1M | $65.6M | $28.8M |
| Capital Expenditures Incurred But Not Yet Paid | $57.3M | $70.3M | $91.8M | $95.3M | $53.2M | $42.8M | $29.1M | $22.1M | $2.2M | $2.2M | $23.0K | $7.0K |
| Additional Paid In Capital | $12.76B | $12.09B | $11.60B | $11.54B | $11.19B | $7.41B | $2.93B | $2.74B | $1.00B | $591.2M | $18.2M | |
| Interest Paid Net | $19.8M | $25.2M | $30.0M | $44.1M | $4.3M | $2.2M | $1.3M | $826.0K | $134.0K | |||
| Earnings Per American Depository Share Basic | $2.63 | -$6.12 | -$8.45 | -$19.43 | -$15.71 | -$19.47 | -$15.80 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $1.05B | $1.06B | $941.2M | $951.4M | $898.2M | $888.1M | $819.0M | $818.0M | $737.3M | $826.0M | $781.0M | $749.9M | $668.8M | $624.8M | $535.7M | $531.2M | $424.5M | $425.8M | $362.4M | $329.2M | $251.6M | $205.3M | $215.9M | $143.4M | $105.3M | $58.0M | $51.5M | $34.8M | $25.0M | $21.0M | $15.4M | $7.9M | |
| Capital Expenditures Incurred But Not Yet Paid | $60.0M | $100.5M | $64.0M | $62.7M | $30.9M | $26.4M | $32.5M | $3.6M | $2.2M | $91.0K | $150.0K | ||||||||||||||||||||||
| Additional Paid In Capital | $12.62B | $12.40B | $12.25B | $11.97B | $11.84B | $11.71B | $11.50B | $11.75B | $11.64B | $11.45B | $11.36B | $11.27B | $7.72B | $7.56B | $7.49B | $7.37B | $5.20B | $5.14B | $2.86B | $2.81B | $2.78B | $2.71B | $1.80B | $1.78B | $981.2M | $604.6M | $597.3M | $388.6M | $385.8M | $384.5M | |||
| Interest Paid Net | $11.4M | $5.0M | $6.6M | $6.9M | $1.1M | $888.0K | $331.0K | $305.0K | |||||||||||||||||||||||||
| Earnings Per American Depository Share Basic | $1.13 | $0.87 | $0.01 | -$1.15 | -$1.15 | -$2.41 | $2.06 | -$3.64 | -$3.34 | -$5.39 | -$5.50 | -$4.25 | -$4.72 | -$5.23 | $0.73 | -$4.70 | $2.79 | -$1.08 |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.